TRUQAP 160 mg/1

TRUQAP 160 mg is a film-coated tablet containing capivasertib, used for targeted therapy. Learn about its uses, effects, and precautions here.

TRUQAP 160 mg is primarily used in targeted therapy to help manage certain types of cancer. Capivasertib, the active ingredient, works by targeting specific proteins involved in cancer cell growth. This medication is often used in combination with other treatments to enhance effectiveness. Patients should consult their healthcare provider to determine if TRUQAP 160 mg is suitable for their specific condition.

Common effects of TRUQAP 160 mg may include fatigue, nausea, and diarrhea. Some users might experience changes in appetite or skin reactions. These effects can vary widely among individuals and are not exhaustive. Always discuss potential effects with a healthcare professional.

TRUQAP 160 mg should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients with certain medical conditions or allergies should inform their doctor before starting this medication. Proper storage and handling can help maintain the effectiveness of the tablets.

TRUQAP 160 mg may interact with other medications, including those that affect liver enzymes. Alcohol and certain foods might also influence its effectiveness. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. Always consult a healthcare professional for personalized advice.